increased incidence intermediate deficiency serum resulting pi phenotype mz reported patients chronic obstructive pulmonary disease copd laboratories confirmed prevalence pi mz determined patients copd NUMBER subjects referred pulmonary function testing laboratory region low concentrations air pollutants control prevalences obtained NUMBER randomly selected subjects community patients copd referred laboratory depending criteria used define copd NUMBER NUMBER subjects copd pi mz prevalence subjects copd varied NUMBER NUMBER times prevalence community control group patients copd difference approached significance significant pi mz present NUMBER NUMBER cent patients copd pi mz major factor etiology copd community higher incidence pi mz inpatients copd reported investigators explained small sample size bias selection study control population groups development copd interaction pi mz air pollutants factors present community alpha1 antitrypsin